A detailed history of Bartlett & Co. LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Bartlett & Co. LLC holds 200 shares of VRTX stock, worth $100,490. This represents 0.0% of its overall portfolio holdings.

Number of Shares
200
Previous 200 -0.0%
Holding current value
$100,490
Previous $70,000 17.14%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

BUY
$221.42 - $260.97 $44,284 - $52,194
200 New
200 $52,000
Q3 2021

Oct 15, 2021

SELL
$181.39 - $202.99 $725 - $811
-4 Closed
0 $0
Q2 2021

Jul 19, 2021

SELL
$187.49 - $221.1 $9,374 - $11,055
-50 Reduced 92.59%
4 $1,000
Q4 2020

Jan 20, 2021

BUY
$207.01 - $276.09 $828 - $1,104
4 Added 8.0%
54 $13,000
Q2 2020

Aug 03, 2020

BUY
$225.48 - $295.8 $11,274 - $14,790
50 New
50 $15,000
Q3 2019

Nov 04, 2019

SELL
$166.23 - $187.09 $5,651 - $6,361
-34 Closed
0 $0
Q2 2019

Jul 24, 2019

BUY
$164.61 - $190.37 $5,596 - $6,472
34 New
34 $6,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Bartlett & Co. LLC Portfolio

Follow Bartlett & Co. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bartlett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bartlett & Co. LLC with notifications on news.